|
XPOT expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.015600E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.818100E-02 |
| Normal-vs-Stage2 |
5.687600E-01 |
| Normal-vs-Stage3 |
2.532000E-02 |
| Normal-vs-Stage4 |
1.171410E-01 |
| Stage1-vs-Stage2 |
1.365970E-01 |
| Stage1-vs-Stage3 |
5.783500E-03 |
| Stage1-vs-Stage4 |
6.356400E-02 |
| Stage2-vs-Stage3 |
9.554300E-02 |
| Stage2-vs-Stage4 |
1.825240E-01 |
| Stage3-vs-Stage4 |
7.602200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.381800E-01 |
| Normal-vs-AfricanAmerican |
3.799400E-01 |
| Normal-vs-Asian |
3.598000E-01 |
| Caucasian-vs-AfricanAmerican |
2.632800E-01 |
| Caucasian-vs-Asian |
3.323800E-01 |
| AfricanAmerican-vs-Asian |
3.022400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.349980E-02 |
| Normal-vs-Female |
3.435600E-03 |
| Male-vs-Female |
2.233100E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.339800E-01 |
| Normal-vs-Extreme_Weight |
7.184600E-04 |
| Normal-vs-Obese |
2.870000E-01 |
| Normal-vs-Extreme_Obese |
6.39609999999458E-05 |
| Normal_Weight-vs-Extreme_Weight |
3.593800E-02 |
| Normal_Weight-vs-Obese |
9.380000E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.637100E-03 |
| Extreme_Weight-vs-Obese |
1.484150E-02 |
| Extreme_Weight-vs-Extreme_Obese |
3.133200E-01 |
| Obese-vs-Extreme_Obese |
3.123200E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.969900E-02 |
| Normal-vs-Age(41-60Yrs) |
8.795200E-01 |
| Normal-vs-Age(61-80Yrs) |
1.868200E-01 |
| Normal-vs-Age(81-100Yrs) |
3.587700E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.192000E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.890400E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.388360E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.260400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.623900E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.537900E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.211870E-04 |
| Normal-VS-Type2 PRCC |
1.193610E-01 |
| Normal-VS-KIRP CIMP |
1.506290E-02 |
| Normal-VS-Unclassified PRCC |
2.159800E-01 |
| Type1 PRCC-VS-Type2 PRCC |
8.216700E-04 |
| Type1 PRCC-VS-KIRP CIMP |
9.375200E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
5.083700E-03 |
| Type2 PRCC-VS-KIRP CIMP |
2.323700E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
9.107800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.253700E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.703550E-01 |
| Normal-vs-N1 |
6.442700E-03 |
| Normal-vs-N2 |
2.763600E-01 |
| N0-vs-N1 |
2.975200E-03 |
| N0-vs-N2 |
2.217600E-01 |
| N1-vs-N2 |
7.569200E-01 |
|
|
